SBIR/STTR Research Award
An Ontology-based Adverse Drug Event Alert Generation System
Award amount
$99,214Program and phase
SBIR · Phase IAward year
2010Award details
- Awarding agency
- Department of Defense
- Branch
- Army
- Recipient company
- SYSNET International, Inc.
- Proposal award date
- 2010-03-15
- Contract end date
- 2010-10-14
- UEI
- Not reported
- Solicitation number
- 2009.3
- Topic code
- OSD09-H12
Research abstract
Medication errors cause the greatest number adverse drug events than any other single cause. Traumatic Brain Injury and Post-Traumatic Stress Disorder patients are especially likely to experience such adverse drug events as a result of the number medications and high dosage levels of the medications that they are prescribed to help them deal with their conditions. Detecting and preventing such adverse drug events is a complex data integration and reasoning problem due to the fact that the individual sources of data that are needed for inferring the potential occurrence of such an event are encoded using disparate medical terminologies and ontologies. SYSNET International, will leverage its extensive experience with clinical data systems integration and with the Military Health System in particular, to develop an ontology-based adverse drug event alert generation system. The system will utilize model-based schema transformation techniques to extract local ontologies from the individual sources of data and then ontology mapping algorithms to align them with a global ontology. A semantic inference engine will be then used to generate potential alerts of adverse drug events.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Development of a Scalable and Extensible Enterprise Master Patient Index for the NHIN
- APPLICATION OF SEMANTIC WEB TECHNOLOGIES TO ALERT PROVIDERS REGARDING POLY-PHARMACY ISSUES IN TRAUMATIC BRAIN INJURY (TBI) AND/OR POST-TRAUMATIC STRES
- APPLICATION OF SEMANTIC WEB TECHNOLOGIES TO ALERT PROVIDERS REGARDING POLY-PHARMACY ISSUES IN TRAUMATIC BRAIN INJURY (TBI) AND/OR POST-TRAUMATIC STRES